Thea Norman

ORCID: 0000-0003-2707-4387
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Computational Drug Discovery Methods
  • Genomics and Rare Diseases
  • Bioinformatics and Genomic Networks
  • Genetics, Bioinformatics, and Biomedical Research
  • Child Nutrition and Water Access
  • Ethics in Clinical Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Gene expression and cancer classification
  • Child Nutrition and Feeding Issues
  • Poverty, Education, and Child Welfare
  • Radiomics and Machine Learning in Medical Imaging
  • Meta-analysis and systematic reviews
  • Global Maternal and Child Health
  • Biochemical and Molecular Research
  • Multiple Myeloma Research and Treatments
  • Statistical Methods in Clinical Trials
  • RNA modifications and cancer
  • Long-Term Effects of COVID-19
  • Prostate Cancer Treatment and Research
  • Chemical Synthesis and Analysis
  • Synthetic Organic Chemistry Methods
  • Gene Regulatory Network Analysis
  • Neurogenetic and Muscular Disorders Research
  • BRCA gene mutations in cancer

Gates Foundation
2019-2024

Global Open University
2024

Sage Bionetworks
2013-2021

Seattle University
2017

AstraZeneca (United States)
2017

University of Utah
2017

University of Turku
2017

Åbo Akademi University
2017

The University of Texas Southwestern Medical Center
2017

Turku Centre for Biotechnology
2017

Selective protein kinase inhibitors were developed on the basis of unexpected binding mode 2,6,9-trisubstituted purines to adenosine triphosphate–binding site human cyclin-dependent 2 (CDK2). By iterating chemical library synthesis and biological screening, potent CDK2–cyclin A complex Saccharomyces cerevisiae Cdc28p identified. The structural for affinity selectivity was determined by analysis a three-dimensional crystal structure CDK2-inhibitor complex. cellular effects these compounds...

10.1126/science.281.5376.533 article EN Science 1998-07-24

<h3>Importance</h3> Mammography screening currently relies on subjective human interpretation. Artificial intelligence (AI) advances could be used to increase mammography accuracy by reducing missed cancers and false positives. <h3>Objective</h3> To evaluate whether AI can overcome interpretation limitations with a rigorous, unbiased evaluation of machine learning algorithms. <h3>Design, Setting, Participants</h3> In this diagnostic study conducted between September 2016 November 2017, an...

10.1001/jamanetworkopen.2020.0265 article EN cc-by-nc-nd JAMA Network Open 2020-03-02

The first report of the ICGC-TCGA DREAM Somatic Mutation Calling Challenge introduces BAMSurgeon tool for accurate tumor simulation and reports performance 248 submissions in calling single-nucleotide variants from three pairs synthetic tumor–normal genome benchmarks. detection somatic mutations cancer sequences is key to understanding genetic basis disease progression, patient survival response therapy. Benchmarking needed assessment improvement but complicated by a lack gold standards,...

10.1038/nmeth.3407 article EN cc-by-nc-sa Nature Methods 2015-05-18

It remains unclear whether causal, rather than merely correlational, relationships in molecular networks can be inferred complex biological settings. Here we describe the HPN-DREAM network inference challenge, which focused on learning causal influences signaling networks. We used phosphoprotein data from cancer cell lines as well silico a nonlinear dynamical model. Using data, scored more 2,000 submitted by challenge participants. The spanned 32 contexts and were terms of validity with...

10.1038/nmeth.3773 article EN cc-by-nc-sa Nature Methods 2016-02-22

Sustainable Development Goal 2.2-to end malnutrition by 2030-includes the elimination of child wasting, defined as a weight-for-length z-score that is more than two standard deviations below median World Health Organization standards for growth

10.1038/s41586-023-06480-z article EN cc-by Nature 2023-09-13
Jade Benjamin‐Chung Andrew Mertens John M. Colford Alan Hubbard Mark J. van der Laan and 95 more Jeremy Coyle Oleg Sofrygin Weixin Cai Anna Nguyen Nolan N. Pokpongkiat Stephanie Djajadi Anmol Seth Wendy Jilek Esther Jung Esther O. Chung Sonali Rosete Nima S. Hejazi Ivana Malenica Haodong Li Ryan Hafen Vishak Subramoney Jonas Häggström Thea Norman Kenneth H. Brown Parul Christian Benjamin F. Arnold Souheila Abbeddou Linda S. Adair Tahmeed Ahmed Asad Ali Hasmot Ali Per Ashorn Rajiv Bahl Maurício L. Barreto France Bégin Pascal Bessong Maharaj Kishan Bhan Nita Bhandari Santosh K. Bhargava Zulfiqar A Bhutta Robert E. Black Ladaporn Bodhidatta Delia B. Carba Inés González-Casanova William Checkley Jean E. Crabtree Kathryn G. Dewey Christopher Duggan Caroline Fall Abu Syed Golam Faruque Wafaie Fawzi José Quirino da Silva Filho Robert H. Gilman Richard L. Guerrant Rashidul Haque Sonja Y. Hess Eric R. Houpt Jean H. Humphrey Najeeha Talat Iqbal Elizabeth Yakes Jimenez Jacob John Sushil Matthew John Gagandeep Kang Margaret Kosek Michael S. Kramer Alain Labrique Sang Lee Aldo Â. M. Lima Mustafa Mahfuz Tjale Cloupas Mahopo Kenneth Maleta Dharma Manandhar Karim Manji Reynaldo Martorell Sarmila Mazumder Estomih Mduma Venkata Raghava Mohan Sophie E. Moore Ishita Mostafa Robert Ntozini Mzwakhe Emanuel Nyathi Maribel Paredes Olórtegui William A. Petri Prasanna Samuel Premkumar Andrew M. Prentice Najeeb Rahman Harshpal Singh Sachdev Kamran Sadiq Rajiv Sarkar Naomi Saville Saijuddin Shaikh Bhim P. Shrestha Sanjaya K. Shrestha Alberto M. Soares Bakary Sonko Aryeh D. Stein Erling Svensen Sana Syed Fayaz Umrani Honorine Ward

Globally, 149 million children under 5 years of age are estimated to be stunted (length more than 2 standard deviations below international growth standards)

10.1038/s41586-023-06418-5 article EN cc-by Nature 2023-09-13
Andrew Mertens Jade Benjamin‐Chung John M. Colford Jeremy Coyle Mark J. van der Laan and 95 more Alan Hubbard Sonali Rosete Ivana Malenica Nima S. Hejazi Oleg Sofrygin Weixin Cai Haodong Li Anna Nguyen Nolan N. Pokpongkiat Stephanie Djajadi Anmol Seth Esther Jung Esther O. Chung Wendy Jilek Vishak Subramoney Ryan Hafen Jonas Häggström Thea Norman Kenneth H. Brown Parul Christian Benjamin F. Arnold Souheila Abbeddou Linda S. Adair Tahmeed Ahmed Asad Ali Hasmot Ali Per Ashorn Rajiv Bahl Maurício L. Barreto Elodie Becquey France Bégin Pascal Bessong Maharaj Kishan Bhan Nita Bhandari Santosh K. Bhargava Zulfiqar A Bhutta Robert E. Black Ladaporn Bodhidatta Delia B. Carba William Checkley Parul Christian Jean E. Crabtree Kathryn G. Dewey Christopher Duggan Caroline Fall Abu Syed Golam Faruque Wafaie Fawzi José Quirino da Silva Filho Robert H. Gilman Richard L. Guerrant Rashidul Haque S. M. Tafsir Hasan Sonja Y. Hess Eric R. Houpt Jean H. Humphrey Najeeha Talat Iqbal Elizabeth Yakes Jimenez Jacob John Sushil Matthew John Gagandeep Kang Margaret Kosek Michael S. Kramer Alain Labrique Sang Lee Aldo Â. M. Lima Tjale Cloupas Mahopo Kenneth Maleta Dharma Manandhar Karim Manji Reynaldo Martorell Sarmila Mazumder Estomih Mduma Venkata Raghava Mohan Sophie E. Moore Robert Ntozini Mzwakhe Emanuel Nyathi Maribel Paredes Olórtegui Césaire T. Ouédraogo William A. Petri Prasanna Samuel Premkumar Andrew M. Prentice Najeeb Rahman Manuel Ramírez‐Zea Harshpal Singh Sachdev Kamran Sadiq Rajiv Sarkar Monira Sarmin Naomi Saville Saijuddin Shaikh Bhim P. Shrestha Sanjaya K. Shrestha Alberto M. Soares Bakary Sonko Aryeh D. Stein Erling Svensen

Abstract Growth faltering in children (low length for age or low weight length) during the first 1,000 days of life (from conception to 2 years age) influences short-term and long-term health survival 1,2 . Interventions such as nutritional supplementation pregnancy postnatal period could help prevent growth faltering, but programmatic action has been insufficient eliminate high burden stunting wasting low- middle-income countries. Identification windows population subgroups on which focus...

10.1038/s41586-023-06501-x article EN cc-by Nature 2023-09-13

The ribosomal incorporation of nonnative amino acids into polypeptides in living cells provides the opportunity to endow therapeutic proteins with unique pharmacological properties. We report here first clinical study a biosynthetic protein produced using an expanded genetic code. Incorporation p -acetylphenylalanine (pAcF) at distinct locations human growth hormone (hGH) allowed site-specific conjugation polyethylene glycol (PEG) produce homogeneous hGH variants. A mono-PEGylated mutant...

10.1073/pnas.1100387108 article EN Proceedings of the National Academy of Sciences 2011-05-16

Fibroblast growth factor 21 (FGF21) mitigates many of the pathogenic features type 2 diabetes, despite a short circulating half-life. PEGylation is proven approach to prolonging duration action while enhancing biophysical solubility and stability. However, in absence specific protein site, chemical conjugation inherently heterogeneous commonly leads dramatic loss bioactivity. This work illustrates novel means PEGylation, producing FGF21 analogs with high activity salutary biological...

10.2337/db11-0838 article EN cc-by-nc-nd Diabetes 2011-12-31
Justin Guinney Tao Wang Teemu D. Laajala Kimberly Kanigel Winner J Christopher Bare and 95 more Elias Chaibub Neto Suleiman A. Khan Peddinti Gopalacharyulu Antti Airola Tapio Pahikkala Tuomas Mirtti Thomas Yu Brian M. Bot Liji Shen Kald Abdallah Thea Norman Stephen Friend Gustavo Stolovitzky Howard R. Soule Christopher J. Sweeney Charles J. Ryan Howard I. Scher Oliver Sartor Yang Xie Tero Aittokallio Fang Liz Zhou James C. Costello Kald Abdallah Tero Aittokallio Antti Airola Catalina Anghe Helia Azima Robert Baertsch Pedro J. Ballester Chris Bare Vinayak Bhandari Brian M. Bot Cuong Cao Dang Maria Bekker‐Nielsen Dunbar Ann‐Sophie Buchardt Ljubomir Buturović Da Cao Prabhakar Chalise Junwoo Cho Tzu‐Ming Chu R. Yates Coley Sailesh Conjeti Sara Correia James C. Costello Ziwei Dai Junqiang Dai Philip Dargatz Sam Delavarkhan Detian Deng Ankur Dhanik Yu Du Aparna Elangovan Shellie D. Ellis Laura L. Elo Shadrielle M. G. Espiritu Fan Fan Ashkan B Farshi Ana Alão Freitas Brooke L. Fridley Stephen Friend Christiane Fuchs Eyal Gofer Gopalacharyulu Peddinti Stefan Graw Russ Greiner Yuanfang Guan Justin Guinney Guo Jing Pankaj Gupta Anna I Guyer Jiawei Han Niels Richard Hansen Billy HW Chang Outi Hirvonen Barbara Huang Chao Huang Jinseub Hwang Joseph G. Ibrahim Vivek Jayaswa Jouhyun Jeon Zhicheng Ji Deekshith Juvvadi Sirkku Jyrkkiö Kimberly Kanigel-Winner Amin Katouzian Marat D. Kazanov Suleiman A. Khan Shahin Khayyer Dalho Kim Agnieszka Kitlas Golińska Devin C. Koestler Fernanda Kokowicz Pilatti Ivan Kondofersky Norbert Krautenbacher Damjan Krstajić

10.1016/s1470-2045(16)30560-5 article EN The Lancet Oncology 2016-11-16

Although molecular prognostics in breast cancer are among the most successful examples of translating genomic analysis to clinical applications, optimal approaches risk prediction remain controversial. The Sage Bionetworks-DREAM Breast Cancer Prognosis Challenge (BCC) is a crowdsourced research study for prognostic modeling using genome-scale data. BCC provided community data analysts with common platform access and blinded evaluation model accuracy predicting survival on basis gene...

10.1126/scitranslmed.3006112 article EN Science Translational Medicine 2013-04-17
Federica Eduati Lara M. Mangravite Tao Wang Jing Tang J Christopher Bare and 95 more Rui Huang Thea Norman Mike Kellen Michael P. Menden Yang Yang Xiaowei Zhan Rui Zhong Guanghua Xiao Menghang Xia Nour Abdo Oksana Kosyk Stephen Friend Gustavo Stolovitzky Allen Dearry Raymond R. Tice Anton Simeonov Ivan Rusyn Fred A. Wright Yang Xie Salvatore Alaimo Alicia Amadoz Muhammad Ammad-ud-din Chloé‐Agathe Azencott Jaume Bacardit Pelham Barron Elsa Bernard Andreas Beyer Bin Shao Alena van Bömmel Karsten Borgwardt April M. Brys Brian E. Caffrey Jeffrey Chang Jungsoo Chang Eleni Christodoulou Mathieu Clément‐Ziza Trevor Cohen Marianne Cowherd Sofie Demeyer Joaquı́n Dopazo Joel D Elhard André O. Falcão Alfredo Ferro David A. Friedenberg Rosalba Giugno Yunguo Gong Jenni Gorospe Courtney A. Granville Dominik G. Grimm Matthias Heinig Rosa Hernansaiz-Ballesteros Sepp Hochreiter Hua Huang Matthew R. Huska Yunlong Jiao Günter Klambauer Michael Kuhn Miron B. Kursa Rintu Kutum Nicola Lazzarini Inhan Lee Michael K. K. Leung Weng Khong Lim C. Liu Felipe Llinares López Alessandro Mammana Andreas Mayr Tom Michoel Misael Mongiovı̀ Jonathan D. Moore R. Narasimhan Stephen O. Opiyo Gaurav Pandey Andrea L. Peabody Juliane Perner Alfredo Pulvirenti Konrad Rawlik Susanne Reinhardt Carol G Riffle Douglas M. Ruderfer Aaron Sander Richard S. Savage Erwan Scornet Patricia Sebastián-León Roded Sharan Carl Johann Simon-Gabriel Véronique Stoven Jingchun Sun Ana Lúcia Teixeira Albert Tenesa Jean‐Philippe Vert Martin Vingron Thomas Walter Sean Whalen Zofia Wiśniewska

When it becomes completely possible for one to computationally forecast the impacts of harmful substances on humans, would be easier attempt addressing shortcomings existing safety testing chemicals. In this paper, we relay outcomes a community-facing DREAM contest prognosticate nature environment-based compounds, considering their likelihood have disadvantageous health-related effects human populace. Our research quantified cytotoxicity levels in 156 compounds across 884 lymphoblastic lines...

10.18034/ajhal.v4i2.577 article EN cc-by-nc Asian Journal of Humanity Art and Literature 2017-12-31

Genetic selections were used to find peptides that inhibit biological pathways in budding yeast. The presented inside cells as peptamers, surface loops on a highly expressed and biologically inert carrier protein, catalytically inactive derivative of staphylococcal nuclease. Peptamers inhibited the pheromone signaling pathway, transcriptional silencing, spindle checkpoint isolated. Putative targets for inhibitors identified by combination two-hybrid analysis genetic dissection target...

10.1126/science.285.5427.591 article EN Science 1999-07-23

The activity of cyclin-dependent kinase 2 (CDK2) is essential for progression cells from G1 to the S phase mammalian cell cycle. CVT-313 a potent CDK2 inhibitor, which was identified purine analog library with an IC50 0.5 μm in vitro. Inhibition competitive respect ATP (K i = 95 nm), and selective had no effect on other, nonrelated ATP-dependent serine/threonine kinases. When added CDK1 or CDK4, 8.5- 430-fold higher concentration required half-maximal inhibition enzyme activity. In exposed...

10.1074/jbc.272.46.29207 article EN cc-by Journal of Biological Chemistry 1997-11-01

ADVERTISEMENT RETURN TO ISSUEPREVCommunicationNEXTA Structure-Based Library Approach to Kinase InhibitorsThea C. Norman, Nathanael S. Gray, John T. Koh, and Peter G. SchultzView Author Information Howard Hughes Medical Institute Department of Chemistry University California Berkeley, 94720 Cite this: J. Am. Chem. Soc. 1996, 118, 31, 7430–7431Publication Date (Web):August 7, 1996Publication History Received6 May 1996Published online7 August inissue 1 January...

10.1021/ja9614934 article EN Journal of the American Chemical Society 1996-01-01
Solveig K. Sieberts Fan Zhu Javier Garcı́a-Garcı́a Eli A. Stahl Abhishek Pratap and 95 more Gaurav Pandey Dimitrios A. Pappas Daniel Aguilar Bernat Anton Jaume Bonet Ridvan Eksi Oriol Fornés Emre Güney Hongdong Li Manuel Alejandro Marín-López Bharat Panwar Joan Planas-Iglesias Daniel Poglayen Jing Cui André O. Falcão Christine Suver Bruce Hoff Venkat S. K. Balagurusamy Donna Dillenberger Elias Chaibub Neto Thea Norman Tero Aittokallio Muhammad Ammad-ud-din Chloé‐Agathe Azencott Víctor Bellón Valentina Boeva Kerstin Bunte Himanshu Chheda Lu Cheng Jukka Corander Michel Dumontier Anna Goldenberg Peddinti Gopalacharyulu Mohsen Hajiloo Daniel Hidru Alok Jaiswal Samuel Kaski Beyrem Khalfaoui Suleiman A. Khan Eric R. Kramer Pekka Marttinen Aziz M. Mezlini Bhuvan Molparia Matti Pirinen Janna Saarela Matthias Samwald Véronique Stoven Hao Tang Jing Tang Ali Torkamani Jean-Phillipe Vert Bo Wang Tao Wang Krister Wennerberg Nathan E. Wineinger Guanghua Xiao Yang Xie Rae S. M. Yeung Xiaowei Zhan Cheng Zhao Manuel Calaza Haitham Elmarakeby Lenwood S. Heath Quan Long Jonathan D. Moore Stephen O. Opiyo Richard S. Savage Jun Zhu Jeff Greenberg Joel Kremer Kaleb Michaud Anne Barton Marieke J. H. Coenen Xavier Mariette Corinne Miceli‐Richard Nancy A. Shadick Michael E. Weinblatt Niek de Vries Paul P. Tak Daniëlle M. Gerlag T. Huizinga Fina Kurreeman Cornelia F Allaart S. Louis Bridges Lindsey A. Criswell Larry W. Moreland Lars Klareskog Saedís Saevarsdóttir Leonid Padyukov Peter K. Gregersen Stephen Friend Robert Plenge Gustavo Stolovitzky Baldo Oliva Yuanfang Guan

Rheumatoid arthritis (RA) affects millions world-wide. While anti-TNF treatment is widely used to reduce disease progression, fails in ∼one-third of patients. No biomarker currently exists that identifies non-responders before treatment. A rigorous community-based assessment the utility SNP data for predicting efficacy RA patients was performed context a DREAM Challenge (http://www.synapse.org/RA_Challenge). An open challenge framework enabled comparative evaluation predictions developed by...

10.1038/ncomms12460 article EN cc-by Nature Communications 2016-08-23

The development of new affordable sensors, and the ability to log high-resolution data for long periods time can potentially revolutionize environmental sciences. Collecting spatiotemporal requires sensor grids that are often costly not necessarily modular enough fit a specific experimental objective. These limiting factors be solved using open-source hardware. In our Open Digital Environmental Lab, we develop integrate complex arrays into research simultaneously measure multiple parameters,...

10.5194/egusphere-egu25-14559 preprint EN 2025-03-15
Robert Kueffner Neta Zach Maya Bronfeld Raquel Norel Nazem Atassi and 95 more Venkatachalapathy S. K. Balagurusamy Barbara Di Camillo Adriano Chiò Merit Cudkowicz Donna Dillenberger Javier Garcı́a-Garcı́a Orla Hardiman Bruce Hoff Joshua Knight Melanie Leitner Guang Li Lara M. Mangravite Thea Norman Liuxia Wang Rached Alkallas Catalina Anghel Jeanne Avril Jaume Bacardit Barbara Balser John Balser Yoav Bar-Sinai Noa Ben-David Eyal Ben‐Zion Robin Bliss Jialu Cai Anatoly Chernyshev Jung-Hsien Chiang Davide Chicco Bhavna Ahuja Nicole Corriveau Junqiang Dai Yash Deshpande Eve Desplats Joseph S. Durgin Shadrielle M. G. Espiritu Fan Fan Philippe Février Brooke L. Fridley Adam Godzik Agnieszka Kitlas Golińska Jonathan Gordon Stefan Graw Yuelong Guo Tim Herpelinck Julia F. Hopkins Barbara Huang Jeremy Jacobsen Samad Jahandideh Jouhyun Jeon Wenkai Ji Kenneth Jung Alex Karanevich Devin C. Koestler Michael J. Kozak Christoph Kurz Christopher M. Lalansingh Thomas Larrieu Nicola Lazzarini Boaz Lerner Wojciech Lesiński Xiaotao Liang Xihui Lin Jarrett Lowe Lester Mackey Richard Meier Wenwen Min Krzysztof Mnich Violette Nahmias Janelle Noel‐MacDonnell Adrienne O’Donnell Susan Paadre Ji Park Aneta Polewko-Klim Rama Raghavan Witold R. Rudnicki Ehsan Saghapour Jean-Bernard Salomond Kris Sankaran Dorota Sendorek Vatsal Sharan Yu-Jia Shiah Jean-Karl Sirois Dinithi Sumanaweera Joseph Usset Yeeleng S. Vang Celine Vens Dave Wadden David Wang Wing Chung Wong Xiaohui Xie Zhiqing Xu Hsih‐Te Yang Xiang Yu Haichen Zhang Li Zhang Shihua Zhang

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease where substantial heterogeneity in clinical presentation urgently requires better stratification of patients for the development drug trials and care. In this study we explored through crowdsourcing approach, DREAM Prize4Life ALS Stratification Challenge. Using data from >10,000 1479 community-based patient registers, more than 30 teams developed new approaches machine learning clustering, outperforming best current...

10.1038/s41598-018-36873-4 article EN cc-by Scientific Reports 2019-01-24

The phenotypes of cancer cells are driven in part by somatic structural variants. Structural variants can initiate tumors, enhance their aggressiveness, and provide unique therapeutic opportunities. Whole-genome sequencing tumors allow exhaustive identification the specific present an individual cancer, facilitating both clinical diagnostics discovery novel mutagenic mechanisms. A plethora variant detection algorithms have been created to enable these discoveries; however, there no...

10.1186/s13059-018-1539-5 article EN cc-by Genome biology 2018-11-06
Coming Soon ...